Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fein

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The American Journal of Cardiology|January 25, 1985
Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapyE H Sonnenblick, F Fein, J M Capasso, et al.
The American Journal of Pathology|July 1, 1984
Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?S M Factor, T Minase, S Cho, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural featuresJ E Strobeck, S M Factor, A Bhan, et al.
Cell Death and Differentiation|October 14, 2003
Unscheduled apoptosis during acute inflammatory lung injuryL L Mantell, J A Kazzaz, J Xu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2016
Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinomaS Kim, S Paget-Bailly, M Messager, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
ESMO Gastrointestinal Oncology|July 6, 2026
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trialA El Kaddissi, A Vienot, J-D Fumet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The American Journal of Cardiology|January 25, 1985
Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapyE H Sonnenblick, F Fein, J M Capasso, et al.
The American Journal of Pathology|July 1, 1984
Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy?S M Factor, T Minase, S Cho, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Hereditary and acquired cardiomyopathies in experimental animals: mechanical, biochemical, and structural featuresJ E Strobeck, S M Factor, A Bhan, et al.
Cell Death and Differentiation|October 14, 2003
Unscheduled apoptosis during acute inflammatory lung injuryL L Mantell, J A Kazzaz, J Xu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 19, 2016
Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinomaS Kim, S Paget-Bailly, M Messager, et al.
Oncoimmunology|May 4, 2018
In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trialO Adotevi, Y Godet, J Galaine, et al.
ESMO Gastrointestinal Oncology|July 6, 2026
Regorafenib and metronomic capecitabine, cyclophosphamide, and aspirin in refractory metastatic colorectal cancer: results from the REPROGRAM-01 single-arm phase II trialA El Kaddissi, A Vienot, J-D Fumet, et al.
Pageof 1